Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
1.
J Stroke Cerebrovasc Dis ; 30(10): 106016, 2021 Oct.
Article de Anglais | MEDLINE | ID: mdl-34325273

RÉSUMÉ

OBJECTIVES: Transient ischemic attack (TIA) can be a warning sign of an impending stroke. The objective of our study is to assess the feasibility, safety, and cost savings of a comprehensive TIA protocol in the emergency room for low-risk TIA patients. MATERIALS AND METHODS: This is a retrospective, single-center cohort study performed at an academic comprehensive stroke center. We implemented an emergency department-based TIA protocol pathway for low-risk TIA patients (defined as ABCD2 score < 4 and without significant vessel stenosis) who were able to undergo vascular imaging and a brain MRI in the emergency room. Patients were set up with rapid outpatient follow-up in our stroke clinic and scheduled for an outpatient echocardiogram, if indicated. We compared this cohort to TIA patients admitted prior to the implementation of the TIA protocol who would have qualified. Outcomes of interest included length of stay, hospital cost, radiographic and echocardiogram findings, recurrent neurovascular events within 30 days, and final diagnosis. RESULTS: A total of 138 patients were assessed (65 patients in the pre-pathway cohort, 73 in the expedited, post-TIA pathway implementation cohort). Average time from MRI order to MRI end was 6.4 h compared to 2.3 h in the pre- and post-pathway cohorts, respectively (p < 0.0001). The average length of stay for the pre-pathway group was 28.8 h in the pre-pathway cohort compared to 7.7 h in the post-pathway cohort (p < 0.0001). There were no differences in neuroimaging or echocardiographic findings. There were no differences in the 30 days re-presentation for stroke or TIA or mortality between the two groups. The direct cost per TIA admission was $2,944.50 compared to $1,610.50 for TIA patients triaged through the pathway at our institution. CONCLUSIONS: This study demonstrates the feasibility, safety, and cost-savings of a comprehensive, emergency department-based TIA protocol. Further study is needed to confirm overall benefit of an expedited approach to TIA patient management and guide clinical practice recommendations.


Sujet(s)
Prestation intégrée de soins de santé/économie , Service hospitalier d'urgences/économie , Coûts hospitaliers , Accident ischémique transitoire/économie , Accident ischémique transitoire/thérapie , Évaluation des résultats et des processus en soins de santé/économie , Sujet âgé , Sujet âgé de 80 ans ou plus , Protocoles cliniques , Économies , Analyse coût-bénéfice , Techniques d'aide à la décision , Études de faisabilité , Femelle , Humains , Accident ischémique transitoire/imagerie diagnostique , Accident ischémique transitoire/mortalité , Durée du séjour/économie , Mâle , Adulte d'âge moyen , Valeur prédictive des tests , Études rétrospectives , Appréciation des risques , Facteurs de risque , Facteurs temps , Résultat thérapeutique , Triage/économie
2.
Stroke ; 51(9): 2664-2673, 2020 09.
Article de Anglais | MEDLINE | ID: mdl-32755347

RÉSUMÉ

BACKGROUND: Anecdotal reports suggest fewer patients with stroke symptoms are presenting to hospitals during the coronavirus disease 2019 (COVID-19) pandemic. We quantify trends in stroke code calls and treatments at 3 Connecticut hospitals during the local emergence of COVID-19 and examine patient characteristics and stroke process measures at a Comprehensive Stroke Center (CSC) before and during the pandemic. METHODS: Stroke code activity was analyzed from January 1 to April 28, 2020, and corresponding dates in 2019. Piecewise linear regression and spline models identified when stroke codes in 2020 began to decline and when they fell below 2019 levels. Patient-level data were analyzed in February versus March and April 2020 at the CSC to identify differences in patient characteristics during the pandemic. RESULTS: A total of 822 stroke codes were activated at 3 hospitals from January 1 to April 28, 2020. The number of stroke codes/wk decreased by 12.8/wk from February 18 to March 16 (P=0.0360) with nadir of 39.6% of expected stroke codes called from March 10 to 16 (30% decrease in total stroke codes during the pandemic weeks in 2020 versus 2019). There was no commensurate increase in within-network telestroke utilization. Compared with before the pandemic (n=167), pandemic-epoch stroke code patients at the CSC (n=211) were more likely to have histories of hypertension, dyslipidemia, coronary artery disease, and substance abuse; no or public health insurance; lower median household income; and to live in the CSC city (P<0.05). There was no difference in age, sex, race/ethnicity, stroke severity, time to presentation, door-to-needle/door-to-reperfusion times, or discharge modified Rankin Scale. CONCLUSIONS: Hospital presentation for stroke-like symptoms decreased during the COVID-19 pandemic, without differences in stroke severity or early outcomes. Individuals living outside of the CSC city were less likely to present for stroke codes at the CSC during the pandemic. Public health initiatives to increase awareness of presenting for non-COVID-19 medical emergencies such as stroke during the pandemic are critical.


Sujet(s)
Encéphalopathie ischémique/épidémiologie , Hémorragies intracrâniennes/épidémiologie , Accident vasculaire cérébral/épidémiologie , Délai jusqu'au traitement/statistiques et données numériques , Sujet âgé , Sujet âgé de 80 ans ou plus , Betacoronavirus , Encéphalopathie ischémique/diagnostic , Encéphalopathie ischémique/physiopathologie , Encéphalopathie ischémique/thérapie , COVID-19 , Études de cohortes , Comorbidité , Connecticut/épidémiologie , Maladie des artères coronaires/épidémiologie , Infections à coronavirus/épidémiologie , Dyslipidémies/épidémiologie , Services des urgences médicales , Ethnies , Femelle , Humains , Hypertension artérielle/épidémiologie , Revenu , Assurance maladie , Hémorragies intracrâniennes/diagnostic , Hémorragies intracrâniennes/physiopathologie , Hémorragies intracrâniennes/thérapie , Mâle , Personnes sans assurance médicale , Adulte d'âge moyen , Évaluation des résultats et des processus en soins de santé , Pandémies , Pneumopathie virale/épidémiologie , Études rétrospectives , SARS-CoV-2 , Indice de gravité de la maladie , Accident vasculaire cérébral/diagnostic , Accident vasculaire cérébral/physiopathologie , Accident vasculaire cérébral/thérapie , Troubles liés à une substance/épidémiologie , Télémédecine , Thrombectomie , Traitement thrombolytique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE